These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 31892344)

  • 1. Nephrolithiasis in gout: prevalence and characteristics of Brazilian patients.
    Hoff LS; Goldenstein-Schainberg C; Fuller R
    Adv Rheumatol; 2019 Dec; 60(1):2. PubMed ID: 31892344
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The efficacy and safety of citrate mixture vs sodium bicarbonate on urine alkalization in Chinese primary gout patients with benzbromarone: a prospective, randomized controlled study.
    Xue X; Liu Z; Li X; Lu J; Wang C; Wang X; Ren W; Sun R; Jia Z; Ji X; Chen Y; He Y; Ji A; Sun W; Zhang H; Merriman TR; Li C; Cui L
    Rheumatology (Oxford); 2021 Jun; 60(6):2661-2671. PubMed ID: 33211886
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the chemical composition of nephrolithiasis using dual-energy CT in Southern Chinese gout patients.
    Li ZX; Jiao GL; Zhou SM; Cheng ZY; Bashir S; Zhou Y
    BMC Nephrol; 2019 Jul; 20(1):273. PubMed ID: 31324154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characteristics of gout patients according to the laterality of nephrolithiasis: A cross-sectional study using helical computed tomography.
    Shimizu T; Hori H; Umeyama M; Shimizu K
    Int J Rheum Dis; 2019 Apr; 22(4):567-573. PubMed ID: 30485677
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of acidic urine pH with impaired renal function in primary gout patients: a Chinese population-based cross-sectional study.
    He Y; Xue X; Terkeltaub R; Dalbeth N; Merriman TR; Mount DB; Feng Z; Li X; Cui L; Liu Z; Xu Y; Chen Y; Li H; Ji A; Ji X; Wang X; Lu J; Li C
    Arthritis Res Ther; 2022 Jan; 24(1):32. PubMed ID: 35078513
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Uricosuric medications for chronic gout.
    Kydd AS; Seth R; Buchbinder R; Edwards CJ; Bombardier C
    Cochrane Database Syst Rev; 2014 Nov; (11):CD010457. PubMed ID: 25392987
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Uric acid nephrolithiasis: current concepts and controversies.
    Shekarriz B; Stoller ML
    J Urol; 2002 Oct; 168(4 Pt 1):1307-14. PubMed ID: 12352383
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of urate-lowering therapies on renal handling of uric acid.
    Ma L; Wei L; Chen H; Zhang Z; Yu Q; Ji Z; Jiang L
    Clin Rheumatol; 2016 Jan; 35(1):133-41. PubMed ID: 25373449
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nephrolithiasis among male patients with newly diagnosed gout.
    Wan KS; Liu CK; Ko MC; Lee WK; Huang CS
    Hong Kong Med J; 2016 Dec; 22(6):534-7. PubMed ID: 27609977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence and risk factors for urolithiasis in primary gout: is a reappraisal needed?
    Alvarez-Nemegyei J; Medina-Escobedo M; Villanueva-Jorge S; Vazquez-Mellado J
    J Rheumatol; 2005 Nov; 32(11):2189-91. PubMed ID: 16265701
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel evaluation of nephrolithiasis as a complication of gout: a cross-sectional study using helical computerized tomography.
    Shimizu T; Kitada H; Umeyama M; Hori H; Takasaki N
    J Urol; 2013 May; 189(5):1747-52. PubMed ID: 23159585
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Hyperuricemia and gout--treatment].
    Gröbner W; Walter-Sack I
    Dtsch Med Wochenschr; 2002 Feb; 127(5):210-3. PubMed ID: 11821994
    [No Abstract]   [Full Text] [Related]  

  • 13. Risk factors associated with renal lithiasis during uricosuric treatment of hyperuricemia in patients with gout.
    Perez-Ruiz F; Hernandez-Baldizon S; Herrero-Beites AM; Gonzalez-Gay MA
    Arthritis Care Res (Hoboken); 2010 Sep; 62(9):1299-305. PubMed ID: 20506124
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of Urolithiasis by Ultrasonography Among Patients with Gout: A Cross-Sectional Study from the UP-Philippine General Hospital.
    Tee M; Lustre Ii C; Abrilla A; Afos IE; Cañal JP
    Res Rep Urol; 2020; 12():423-431. PubMed ID: 33062621
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Excellent response to the clinical treatment of tophaceous gout.
    Caldas CA; Fuller R
    Clin Rheumatol; 2007 Sep; 26(9):1553-5. PubMed ID: 17047891
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biochemical profile of idiopathic uric acid nephrolithiasis.
    Pak CY; Sakhaee K; Peterson RD; Poindexter JR; Frawley WH
    Kidney Int; 2001 Aug; 60(2):757-61. PubMed ID: 11473659
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The prevalence of nephrolithiasis in patients with primary gout: a cross-sectional study using helical computed tomography.
    Shimizu T; Hori H
    J Rheumatol; 2009 Sep; 36(9):1958-62. PubMed ID: 19605673
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potassium citrate decreases urine calcium excretion in patients with hypocitraturic calcium oxalate nephrolithiasis.
    Song Y; Hernandez N; Shoag J; Goldfarb DS; Eisner BH
    Urolithiasis; 2016 Apr; 44(2):145-8. PubMed ID: 26582172
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nephrolithiasis in Cushing's disease: prevalence, etiopathogenesis, and modification after disease cure.
    Faggiano A; Pivonello R; Melis D; Filippella M; Di Somma C; Petretta M; Lombardi G; Colao A
    J Clin Endocrinol Metab; 2003 May; 88(5):2076-80. PubMed ID: 12727957
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of urate-lowering drugs on the progression and recovery from chronic kidney disease among gout patients.
    Chung TT; Yu KH; Kuo CF; Luo SF; Chiou MJ; Lan WC; Chen JS; Tseng WY; Hsieh AH; Wang LC
    Arthritis Res Ther; 2019 Sep; 21(1):210. PubMed ID: 31533805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.